Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1158.88	565.66	44.93
Graham Fair Price	-28.38	4.05	5.65
PEG	180.44	-0.26	0.09
Price/Book	1.16	0.62	0.61
Price/Cash Flow	12359.72	2299.31	18.45
Prices/Earnings	98.86	38.70	-19.46
Price/Sales	54.28	11.34	7.35
Price/FCF	12359.72	2299.31	18.45
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	26.72	0.82	0.65
Operating Margin	36.43	-0.09	-0.13
ROA	-49.43	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-49.13
ROIC	< 0.005	< 0.005	71.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.14	-72.30
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.71	0.58	-65.98
EPS QOQ	-2.10	1.49	-29.09
FCF QOQ	1.08	-0.99	-8.56
Revenue QOQ	0.25	-0.34	36.34
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.75	2.25	199.71
Days Sales Outstanding (DSO)	187.37	67.08	-64.20
Inventory Turnover	119.73	39.95	-66.63
Debt/Capitalization	0.22	0.23	3.16
Quick Ratio	2.19	1.86	-15.14
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.47	13.53	0.42
Cash	4.09	4.52	10.60
Capex	-0.05	-0.07	-31.70
Free Cash Flow	0.44	< 0.005	-99.18
Revenue	1.12	0.73	-34.16
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.06	2.35	14.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.17	28.81	1227.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating